1Schmidt LE, Sorensen VR, Svendsen LB, et al. Improvement of systemic vascular resistance and arterial pressure in patients with acute or chronic liver failure during treatment with the molecular adsorbent recycling system(MARS) [abstract][J]. Hepatology,2
2Sorkine P, Abraham RB, Szold O, et al. Role of molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure [abstract][J]. Z Gastroenterol,2001,39 (S2):40-41.
3Notohamiprodjo M, Banayosy A, Kizner L,et al.One year experience with MARS-therapy in patients with multiple organ failure in Cardiac Center Bad Oeyenhausen[abstract][J].Z Gastroenterol,2001,39(S2):51.
4Peek GJ,Killer HM,Sosnowsk MA,et al.Modular extracorporeal life support for multiorgan failure patients[J]. Liver ,2002, 22(S2): 69-71.
5Jalan H,Kapoor D,Steiner C,et al.MARS in decompensated alcoholic liver disease with multi-organ failure[J]. Z Gastroenterol,2001,39(suppl S2):12.
7Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care[J]. Crit Care Med,2001,29:1303-1310.
8Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM Consensus Conference Committee.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101:1644-1645.
9Rpnco GL,Brendolan AL,Dan MA,et al.Absorption in sepsis[J].Kidney Int,2000,76(suppl):148-155.
10Mitzner SR, Stange J, Klammt S,et al.Albumin dialysis using the molecular adsorbent recirculating system[J]. Current Opinion in Nephrology and Hypertension, 2001,10: 777-783.
